NovaBay Pharma (NBY) Tops Q4 EPS by 2c, Beats on Revenues
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Research and development: 4K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 4K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Note: EPS may not be comparable
NovaBay Pharma (NYSE: NBY) reported Q4 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $6.32 million versus the consensus estimate of $5.97 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
